Tech Entrepreneur Paul Conyngham Uses mRNA Vaccine (Developed With The Help Of ChatGPT) As An Experimental Treatment For Pet Dog’s Cancer
According to Dawn News, a Sydney based tech entrepreneur Paul Conyngham developed mRNA vaccine with the help of ChatGPT as an experimental treatment for pet dog’s cancer.
Rosie – an eight year old dog was adopted by Paul Conyngham in 2019. In 2024, it was revealed that she was diagnosed with a deadly mast cell cancer.
Initial treatment by Paul Conyngham failed to produce conducive results. He took it to ChatGPT to brainstorm ideas and processes which lead to him to work with top medical scientists to find a cure.
The vaccine which was given in Christmas of 2025, shrunk Rosie’s tumour by half astounding scientists.
This revelation poses a significant question? Can more daring people like Paul Conyngham use AI chatbots for medical discoveries? Or will humanity continue to wait and trust large medical corporations and governments to circulate reliable vaccines to the general public.
The move to ‘open-platform’ vaccination invention could be great for humanity but also pose significant risk to large corporations’ profitability.
Find this article interesting? Check out our previous medical related article on Stem Cell Therapy for Type 1 and Type 2 Diabetes.
